Pharma Company Expands Capabilities with New Peptide Research Center Pharma Company Expands Capabilities with New Peptide Research Center The company's Price-Earnings (PE) Ratio stands at 165.54. DSIJ Intelligence / Saturday, April 5, 2025 0 104 Article rating: 3.7 Major public shareholders include Tpg Asia Vii Sf Pte Ltd with 24.78 per cent, HBM Private Equity India with 1.99 per cent, Anitha Rudraraju Nandyala with 1.73 per cent, Raju Penmasta with 1.11 per cent and Penmasta Aruna with 1.02 per cent. Read more
Pharma Company Enters Into Share Purchase Agreement and Power Supply Agreement with Torrent Urja 19 Pvt Ltd Pharma Company Enters Into Share Purchase Agreement and Power Supply Agreement with Torrent Urja 19 Pvt Ltd The company has a market cap of over Rs 13,000 crore and the stock is up 45 per cent from its 52-week low of Rs 743.60 per share. DSIJ Intelligence / Thursday, April 3, 2025 0 128 Article rating: 4.5 The company has a market cap of over Rs 13,000 crore and the stock is up 45 per cent from its 52-week low of Rs 743.60 per share. Read more
Pharma Penny Stock Under Rs 50 Jumps Over 5 Per Cent on April 03; Do you Have It? Pharma Penny Stock Under Rs 50 Jumps Over 5 Per Cent on April 03; Do you Have It? From Rs 34 per share (52-week low) to Rs 38.90 per share, the stock is up by 14.4 per cent. DSIJ Intelligence / Thursday, April 3, 2025 0 229 Article rating: 4.5 From Rs 34 per share (52-week low) to Rs 38.90 per share, the stock is up by 14.4 per cent. Read more
46 Per Cent Returns From 52-Week Low: Pharma Stock Under Rs 75, Hit 10 Per Cent Upper Circuit; Here’s Why 46 Per Cent Returns From 52-Week Low: Pharma Stock Under Rs 75, Hit 10 Per Cent Upper Circuit; Here’s Why The company has a market cap of over Rs 400 crore and the stock is up by 46 per cent from its 52-week low of Rs 50.42 per share. DSIJ Intelligence / Thursday, April 3, 2025 0 124 Article rating: 5.0 The company has a market cap of over Rs 400 crore and the stock is up by 46 per cent from its 52-week low of Rs 50.42 per share. Read more
Multibagger Pharma Company Expands into New Territory with Innovative Pediatric Solution Multibagger Pharma Company Expands into New Territory with Innovative Pediatric Solution The stock has delivered 85 per cent in 1 year and gave multibagger returns of 240 per cent in 2 years. DSIJ Intelligence / Saturday, March 22, 2025 0 152 Article rating: 5.0 The stock has delivered 85 per cent in 1 year and gave multibagger returns of 240 per cent in 2 years. Read more